Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey

BACKGROUND/AIMS: As the most common liver disease in hemodialysis patients, chronic hepatitis C (CHC) can cause cirrhosis and hepatocellular carcinoma, even increase in renal-related mortality. In Turkey, the frequency of anti-hepatitis C virus (HCV) antibodies in hemodialysis patients ranged from 3...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Turk J Gastroenterol
Asıl Yazarlar: Yaraş, Serkan, Üçbilek, Enver, Özdoğan, Osman, Ateş, Fehmi, Altıntaş, Engin, Sezgin, Orhan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Turkish Society of Gastroenterology 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6453652/
https://ncbi.nlm.nih.gov/pubmed/30666967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2018.18269
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller